Ali Kadri ÇIRAK, Yelda VAROL, Nimet AKSEL, Hülya Doğan ŞAHİN

Which scoring system is better in association with exercise capacity and health status in noncystic fibrosis bronchiectasis patients?

Background/aim: Two different scoring systems were developed to determine the severity of bronchiectasis: FACED scoring and the bronchiectasis severity index (BSI). In this study, we aim to compare these 2 scoring systems according to the 6-min walking distance test and a disease-specific health status questionnaire in patients with noncystic fibrosis bronchiectasis (NCFB). Materials and methods: Smoking history, emergency and hospital admissions, and body mass index were obtained from NCFB patients admitted to our hospitals’ pulmonary rehabilitation unit between 2013 and 2018. Detailed pulmonary function tests were performed for all participants. Dyspnea perceptions were determined according to the mMRC dyspnea scale. The 6-min walking test was used to determine exercise capacity. The Saint George respiratory questionnaire (SGRQ) was applied to determine health status. Both FACED and BSI scores were calculated for all participants. Results: There were a total of 183 participants, 153 of whom were men. A significant and strong correlation was found between FACED and BSI scores. As the severity of bronchiectasis increased, walking distance was significantly decreased and health status was significantly worse in both FACED and BSI scoring. A statistically significant but weak negative correlation was found between FACED score and walking distance. There was a significant negative correlation between BSI and walking distance, a stronger negative correlation than with FACED. Similarly, there was a significant negative correlation between health status and both FACED and BSI, but this correlation was stronger in the BSI score. Conclusion: Although both FACED and BSI scores were negatively correlated with walking distance and health status in patients with NCFB, BSI was more strongly associated.Key words: Noncystic fibrosis bronchiectasis, FACED score, BSI score, 6-min walking distance, health status

PDF

___

1. Boucher RC. Muco-obstructive lung diseases. The New England Journal of Medicine 2019; 380 (20): 1941-1953. doi: 10.1056/NEJMra1813799
2. King P, Holdsworth S, Freezer N, Holmes P. Bronchiectasis. Internal Medicine Journal 2006; 36 (11): 729-737. doi: 10.1111/j.1445-5994.2006.01219.x
3. Martínez-García MÁ, De Gracia J, Vendrell Relat M, Girón RM, Máiz Carro L et al. Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score. European Respiratory Journal 2014; 43 (5): 1357-1367. doi: 10.1183/09031936.00026313
4. Chalmers JD, Goeminne P, Aliberti S, McDonnell MJ, Lonni S et al. The Bronchiectasis Severity Index: an international derivation and validation study. American Journal of Respiratory and Critical Care Medicine 2014; 189 (5): 576- 585. doi: 10.1164/rccm.201309-1575OC
5. Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F et al. ATS/ERS task force. General considerations for lung function testing. European Respiratory Journal 2005; 26 (1): 153-161. doi: 10.1183/09031936.05.00034505
6. Bausewein C, Farquhar, M, Booth S, Gysels M, Higginson IJ. Measurement of breathlessness in advanced idsease: a systematic review. Respiratory Medicine 2007; 101 (3): 399- 410. doi: 10.1016/j.rmed.2006.07.003
7. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. American Journal of Respiratory and Critical Care Medicine 2002; 166 (1): 111-117. doi: 10.1164/ ajrccm.166.1.at1102
8. Polatlı M, Yorgancıoğlu A, Aydemir Ö, Yılmaz Demirci N, Kırkıl G et al. Validity and reliability of Turkish version of St. George’s respiratory questionnaire. Tüberküloz ve Toraks 2013; 61 (2): 81-87. doi: 10.5578/tt.5404 (Turkish with an abstract in English)
9. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 1983; 67: 361-70. doi: 10.1111/j.1600-0447.1983.tb09716.x
10. Polverino E, Gemine PC, McDonnell MJ, Aliberti S, Marshall SE et al. European Respiratory Society guidelines for the management of adult bronchiectasis. European Respiratory Journal 2017; 50 (3): 1700629. doi: 10.1183/13993003.00629- 2017
11. McDonnell MJ, Aliberti S, Goeminne PC, Dimakou K, Zucchetti SC et al. Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts. Thorax 2016; 71 (2): 1110-1118. doi: 10.1136/thoraxjnl-2016-208481
12. Aliberti S, Lonni S, Dore S, McDonnell MJ, Goeminne PC et al. Clinical phenotypes in adult patients with bronchiectasis. European Respiratory Journal 2016; 47: 1113-1122. doi: 10.1183/13993003.01899-2015
13. Hurst JR, Elborn JS, De Soyza A. COPD-bronchiectasis overlap syndrome. European Respiratory Journal 2015; 45 (2): 310- 313. doi: 10.1183/09031936.00170014
14. Chalmers JD. Bronchiectasis and COPD overlap: a case of mistaken identity? Chest 2017; 151 (6): 1204-1206. doi: 10.1016/j.chest.2016.12.027
15. Machado BC, Jacques PS, Penteado LP, Roth Dalcin PT. Prognostic factors in adult patients with non-cystic Fibrosis Bronchiectasis. Lung 2018; 196 (6): 691-697. doi: 10.1007/ s00408-018-0165-z
16. Wang H, Ji XB, Li CW, Lu HW, Mao B et al. Clinical characteristics and validation of bronchiectasis severity score systems for post-tuberculosis bronchiectasis. The Clinical Respiratory Journal 2018; 12 (8): 2346-2353. doi: 10.1111/ crj.12911
17. Ellis HC, Cowman S, Fernandes M, Wilson R, Loebinger MR. Predicting mortality in bronchiectasis using bronchiectasis severity index and FACED scores: a 19-year cohort study. European Respiratory Journal 2016; 47 (2): 482-489. doi: 10.1183/13993003.01312-2015
18. Guan W, Chen R, Zhong N. The bronchiectasis severity index and FACED score for bronchiectasis. European Respiratory Journal 2016; 47 (2), 382-384. doi: 10.1183/13993003.01717- 2015